Countries covered: Global
Vaccines were among the biggest medical breakthroughs of the 20th century. In the past
2 years, more than 15 new gene and immunotherapy medicines have come to market and at least 25 products are in late stage clinical trials.
Theta’s report covers trends and advancements in global vaccines markets that have occurred in 2001 and 2002. This study spotlights emerging therapeutic vaccine markets and focuses on novel therapeutics based on gene therapy, immunoproteins, and antibodies.
Key issues discussed in this report:
1. Markets and advancements in:
· preventative pediatric vaccines
· adult at-risk vaccines
· therapeutic vaccines (including those based on antibodies, immunoproteins, DNA epitopes)
2. Delivery systems engineered to target diseased cells
3. Review of the progress in disease vaccine development for:
· cancer
· autoimmune disease
· cardiovascular disease
· gastrointestinal disorders
· sexually transmitted diseases
· infectious diseases
4. Profiles of the top vaccine companies, with mini-profiles of selected innovators Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Related Reports:
Drug Price/Cost Debate: Coping with Escalating Pricing Pressures
Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
DiseaseINFOPACK: Clostridium difficile in China
Freedonia Focus on Biologicals
Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook
Preventive Healthcare Technologies, Products and Markets
Immunotherapies and Vaccines for Nontraditional Indications
The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
MarketVIEW: Group B Streptococcus vaccines
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
|
(0 items)
